Friday 6 November 2026 Export BIO’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue: +0.52%
EPS: +234.8%
Free cash flow: +8.07%
Total debt: +0.11%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

382.51 13.51 +3.66%

Follow BIO

Alert me

Market cap: $9.9B
P/E: 10.0×
Fwd P/E: 44.7×
Dividend yield: —
F-score: 5/9
Altman Z: 3.20
Beneish M: −2.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	10.84	45.62	35.25	9.90
P/S ratio Full definition →		3.20	2.90	3.03	3.90
P/FCF ratio Full definition →		21.93	20.91	22.11	30.55
P/Operating CF Full definition →		50.09	69.51	79.56	104.93
P/B ratio Full definition →		1.11	1.10	1.09	1.33
Price to Tangible BV Full definition →		1.23	1.23	1.22	1.46
EV/Sales Full definition →		3.07	2.76	2.87	3.72
EV/EBITDA Full definition →		167.85	124.19	140.08	0.00
EV/Operating CF Full definition →		14.89	14.02	15.10	20.63
EV/FCF Full definition →		21.03	19.90	20.95	29.16
Quick Ratio Full definition →		3.87	2.17	2.14	2.15
Current Ratio Full definition →		5.62	3.21	3.14	3.18
Net Debt/EBITDA Full definition →		2.84	(10.60)	(5.71)	9.26
Debt/Assets Full definition →		11.37%	12.29%	11.74%	11.17%
Debt/Equity Full definition →		0.16	0.18	0.17	0.16
Asset Turnover Full definition →		0.26	0.27	0.25	0.25
Operating CF/Net income Full definition →		0.23	(0.21)	0.27	0.21
Capex/Depreciation Full definition →		(0.28)	0.00	0.00	0.00
Interest Coverage Full definition →		(9.83)	2.77	6.00	(4.04)
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	9.40%	10.88%
Selling, General and Administrative Expense of Revenue Full definition →		31.88%	35.87%	32.57%	39.17%
Intangible Assets out of Total Assets Full definition →		0.07	0.08	0.07	0.06
Share Based Compensation of Revenue Full definition →		8.37%	0.00%	0.00%	0.00%
Graham Net Nets Full definition →		(0.03)	0.00	(0.01)	(0.01)
Graham Number Full definition →		414.65	186.92	224.21	493.69
Earnings Yield Full definition →		9.22%	2.19%	2.84%	10.10%
Free Cash Flow Yield Full definition →		4.56%	4.78%	4.52%	3.27%
Revenue per Share Full definition →		25.43	21.96	24.34	24.51
Operating CF per Share Full definition →		6.05	4.01	3.69	3.60
Capex per Share Full definition →		(1.68)	(1.11)	(1.20)	(1.16)
Free Cash Flow per Share Full definition →		4.37	2.90	2.49	2.43
Cash per Share Full definition →		56.51	58.04	60.51	62.15
Shareholders Equity per Share Full definition →		273.40	254.15	268.22	283.91
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		273.40	254.15	268.22	283.91
Free Cash Flow Full definition →		119.10	78.20	66.60	65.20
Working Capital Full definition →		2,389.20	2,025.10	2,059.20	2,109.50
Capital Expenditures Full definition →		(45.80)	(29.90)	(32.10)	(31.20)
Net Current Asset Value Full definition →		(216.70)	3.40	(57.60)	(101.50)
EV/EBIT Full definition →		167.85	124.19	140.08	0.00
Capex to Sales Full definition →		0.07	0.05	0.05	0.05
Price to Operating Income Full definition →		175.01	130.46	147.89	0.00
Other line items
Average Receivables Full definition →		456.55	425.45	455.85	443.65
Average Payables Full definition →		125.65	135.50	141.40	131.15
Average Inventory Full definition →		750.35	780.30	789.70	783.55
Average Assets Full definition →		9,970.30	9,658.45	10,233.05	10,239.75
Average Common Equity Full definition →		7,011.45	6,765.35	7,151.30	7,169.90

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly